1,0
18 set 2024
Dipendente anonimo
Dipendente attuale, più di 3 anni
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Meh. The McDonald's of Pharma.
Svantaggi
Not the Wendy's of Pharma. Sticks to the status quo, even for innovation which slaps them in the face with something that could lead to a wide range of ROI and growth. Retrofits innovative ideas into policy and discussions never to actually innovate with a growth mindset, but with a "this is how we do it and its always been" idealism. Too many "pick me" "look at me" workers and not enough collaboration to actually learn and feed off of innovative ideas.